Basics
Description
- Most common cancer in US
- Increasing incidence
- 1 in 6 will have skin cancer during their lifetime
- Actinic keratosis:
- Premalignant lesion
- Thickened scaly growth caused by sunlight or other artificial light source
- Found on areas of body with high sun exposure
- 0.1 " 10% may transform into squamous cell carcinoma (SCC)
- Nonmelanoma skin cancer:
- Less commonly fatal
- Fast growing
- May be destructive if left untreated
- Basal cell carcinoma (BCC):
- Cells arise from epidermis
- Most common skin cancer
- Account for 75% of all nonmelanoma skin cancers
- Male > female, 3:2.
- Locally invasive without risk of distant metastasis
- Most important risk factor is sun exposure
- More common in fair-skinned patients
- Most lesions are on the head and neck
- SCC:
- 2nd most common skin cancer
- 20% of cases of skin cancer
- Most arise from precancerous actinic keratosis lesions
- Male > female
- Most important risk factor is sun exposure, especially sunburn
- 70% occur on head and neck
- More common in older, fair-skinned patients
- Risk of regional lymph node and distant metastasis
- SCC lesions of mucosal surfaces are more aggressive
- Melanoma:
- 5% of all diagnosed skin cancer in US
- 62,000 new cases in 2008
- 15% are fatal
- 75% of skin cancer cause deaths
- Arises from melanin-producing cells
- Most important risk factor is sun exposure, especially sunburn
- Additional risk factors:
- Fair skin; blond/red hair
- Multiple common melanocytic nevi
- Atypical nevi
- Immunosuppression
- Positive family history
- History of nonmelanoma skin cancer (BCC or SCC)
- ≥5 sunburns in early life doubles the risk for malignant melanoma
- Risk of regional lymph node and distant metastasis
Etiology
- UV irradiation:
- Both UVA and UVB rays
- Sun exposure
- Tanning beds
- SCC often associated with human papilloma virus (HPV)
- Immunosuppression may predispose to SCC
- Vitamin D metabolism may play a role
Diagnosis
Signs and Symptoms
- Actinic keratosis:
- Rough, pink, circumscribed lesions <1 cm in diameter
- A lesion may have both actinic keratosis and SCC
- BCC:
- May be single or multiple
- Usually painless
- Usually appears in sun-exposed areas of skin
- Erosion or bleeding with mild trauma may be 1st symptoms
- Nodular BCC:
- Most common
- Waxy or pearly papule, possibly with telangiectasia
- Well-demarcated borders
- May have central ulceration
- Pigmented BCC:
- Similar to nodular BCC with brown, blue, or black coloration
- Often mistaken for superficial spreading or nodular melanoma
- Cystic BCC:
- Bluish/gray cystic nodules
- May be mistaken for benign cysts
- Superficial BCC:
- Scaly patch-like or papule surrounded by small, clear micropapules
- Pink, red, or brown
- Micronodular BCC:
- Well-defined border
- Aggressive
- Rarely with ulceration
- Morpheaform BCC:
- Poorly defined borders
- May appear "scar like "
- Aggressive
- Ulceration and bleeding are rare
- SCC:
- Characteristic lesion is raised, firm, keratotic papule or plaque
- Often enlarging
- Usually asymptomatic but may be ulcerated and painful as invasion occurs
- Ulcers often crust and ooze
- Cranial nerve involvement may indicate an aggressive tumor with perineural invasion:
- Facial numbness, asymmetry, weakness, or pain
- Melanoma:
- Pigmented skin lesion:
- Features suggestive of melanoma (the ABCDEs of melanoma):
- Asymmetry (not regularly round or oval)
- Border irregularity (notched or poorly defined)
- Bleeding (spontaneous)
- Color variegation (shades or combinations of brown, tan, red, white, or blue-black)
- Diameter >6 mm
- Elevation/Enlargement
- Lesions rarely symptomatic unless ulcerated
- Superficial spreading melanoma:
- 70% of all malignant melanomas
- May have a wide variety of colors
- Often arise from dysplastic nevus
- Usually <3 cm
- Slight elevation and induration is common
- Often have satellite lesions
- Nodular melanoma:
- 10 " 15% of melanomas
- The most symmetric of the different melanomas
- Dark brown or black
- Often exophytic
- Lentigo maligna melanomas (LMM):
- Always starts as lentigo maligna, a macular insitu malignancy which is an evolving lesion of melanoma
- LMM occurs after the lesion begins vertical growth into the dermis " typically indicated by papular or nodular areas
- Irregular shape and multiple colors
- Acral lentiginous melanoma:
- Equal among black and white patients
- Most common form of melanoma found in Asians and African Americans
- Occur on palms, soles, and subungual region with predilection for soles of feet
- May be mistaken for subungual hematoma
- Involvement of the proximal nail fold (Hutchinson sign) is an indicator of melanoma
- Mucosal lentiginous melanoma:
- Develops from mucosal epithelium in respiratory, GI, and GU tracts
- Often diagnosed at a later stage of disease
- Very rare
- Metastatic melanoma:
- Presentation related to affected organ system
- Lymphangitic spread with local to regional lymphadenopathy
- Typical visceral sites of hematogenous spread include liver, lung, bone, brain, and intestines
Essential Workup
All suspicious lesions require biopsy, a procedure rarely done in ED
Diagnosis Tests & Interpretation
Lab
No specific testing is required
Imaging
- CXR may show pulmonary involvement by metastatic melanoma
- Head or body CT scan may show visceral involvement by metastatic SCC or melanoma
- Cross-sectional imaging does not rule out metastasis
Diagnostic Procedures/Surgery
Biopsy usually performed by consultant
Differential Diagnosis
- For BCC:
- SCC
- Bowen disease
- Actinic keratosis
- Paget disease
- Benign nevus
- Melanoma
- For SCC:
- Actinic keratosis
- BCC
- Keratoacanthoma
- Melanoma
- Wart
- For melanoma:
- Atypical nevus
- Common nevus
- Actinic keratosis
- Pigmented BCC
- SCC
Treatment
Pre-Hospital
No specific pre-hospital care is required
Initial Stabilization/Therapy
- No specific stabilization is usually required beyond basic wound care
- Stabilization may be required for invasion into vascular structures or edema from intracranial metastasis
Ed Treatment/Procedures
- Skin lesions themselves require no specific ED treatment
- Treat complications of visceral involvement by metastatic melanoma, SCC or locally invasive BCC.
Follow-Up
Disposition
Admission Criteria
- Admission typically only occurs due to complications associated with visceral involvement or invasive spread
- Admission is rarely required because of the dermatologic lesions themselves
Discharge Criteria
Patients are generally discharged with instructions on obtaining biopsy and/or further evaluation
Issues for Referral
Discharged patients should be advised to consult a dermatologist or primary care physician experienced with skin biopsy.
Follow-Up Recommendations
- Biopsy is required for diagnosis of skin cancer
- Urgent follow-up with dermatologist or primary care physician is advised
- Ensure adequate documentation of conversation with patient regarding urgency of follow-up
- Patients with nonmelanoma skin cancer have a 30 " 50% chance of developing additional skin cancer within 5 yr
Pearls and Pitfalls
- Advise patient to obtain urgent follow-up for any suspicious lesion
- 1 in 6 people will have skin cancer during their lifetime
- Protection from UVA and UVB rays is key to preventing skin cancer
Additional Reading
- Arora A, Attwod J. Common skin cancers and their precursors. Surg Clin North Am. 2009;89:703 " 712.
- Califano J, Nance M. Malignant melanoma. Facial Plast Surg Clin North Am. 2009;17:337 " 348.
- Firnhaber JM. Diagnosis and treatment of basal cell and squamous cell carcinoma. Am Fam Physician. 2012;86:161 " 168.
- Lee DA, Miller SJ. Nonmelanoma skin cancer. Facial Plast Surg Clin North Am. 2009;17:309 " 324.
- Ricotti C, Bouzari N, Agadi A, et al. Malignant skin neoplasms. Med Clin North Am. 2009;93:1241 " 1264.
Codes
ICD9
- 173.90 Unspecified malignant neoplasm of skin, site unspecified
- 173.91 Basal cell carcinoma of skin, site unspecified
- 173.92 Squamous cell carcinoma of skin, site unspecified
- 172.9 Melanoma of skin, site unspecified
- 173.30 Unspecified malignant neoplasm of skin of other and unspecified parts of face
- 173.40 Unspecified malignant neoplasm of scalp and skin of neck
- 173.99 Other specified malignant neoplasm of skin, site unspecified
- 173.9 Other and unspecified malignant neoplasm of skin, site unspecified
- 702.0 Actinic keratosis
ICD10
- C44.90 Unspecified malignant neoplasm of skin, unspecified
- C44.91 Basal cell carcinoma of skin, unspecified
- C44.92 Squamous cell carcinoma of skin, unspecified
- C43.9 Malignant melanoma of skin, unspecified
- C44.300 Unsp malignant neoplasm of skin of unspecified part of face
- C44.40 Unspecified malignant neoplasm of skin of scalp and neck
- C44.99 Other specified malignant neoplasm of skin, unspecified
- C44.9 Other and unsp malignant neoplasm of skin, unspecified
- L57.0 Actinic keratosis
SNOMED
- 372130007 Malignant neoplasm of skin (disorder)
- 254651007 Squamous cell carcinoma of skin (disorder)
- 254701007 Basal cell carcinoma of skin (disorder)
- 372244006 Malignant melanoma (disorder)
- 201101007 Actinic keratosis (disorder)
- 372122006 Malignant neoplasm of skin head and neck (disorder)
- 443136000 malignant neoplasm of skin of face (disorder)